Synapse - Mark Geyer

Results (91)

Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia

Correspondence

Gaulin, C.; Chan, A.; Derkach, A.; Park, J. H.; Mantha, S.; Geyer, M. B.; Tallman, M. S.
Leukemia and Lymphoma (2020)

Fulltext@MSK | Save

FGFR1 rearrangement guides diagnosis and treatment of a trilineage B, T, and myeloid mixed phenotype acute leukemia

Journal Article

Liu, Y.; Mi, X.; Gadde, R.; Gao, Q.; Xiao, W.; Zhang, Y.; Benayed, R.; Arcila, M.; Dogan, A.; Geyer, M. B.; more...
JCO Precision Oncology (2020)

Fulltext@MSK | Save

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Journal Article

Roeker, L. E.; Dreger, P.; Brown, J. R.; Lahoud, O. B.; Eyre, T. A.; Brander, D. M.; Skarbnik, A.; Coombs, C. C.; Kim, H. T.; Davids, M.; more...
Blood Advances (2020)

Fulltext@MSK | Save

Phase I/II triple therapy study of umbralisib and ublituximab ("U2") combined with checkpoint inhibition in patients with rel/ref CLL and Richter's transformation

Meeting Abstract

Mato, A.; Svoboda, J.; Luning-Prak, E.; Schuster, S.; Tsao, P.; Dorsey, C.; Sarmasti, L.; Becker, P.; Brander, D.; Geyer, M.; more...
Leukemia and Lymphoma (2020)

Fulltext@MSK | Save

Inotuzumab ozogamicin is an effective salvage therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with high-risk molecular features, including TP53 loss

Meeting Abstract

Yang, X.; King, A. C.; Kabel, C. C.; Forlenza, C. J.; Park, J. H.; Geyer, M. B.
Blood (2019)

Fulltext@MSK | Save

Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients

Meeting Abstract

Ujjani, C. S.; Roeker, L. E.; Shadman, M.; Whitaker, K. J.; Jacob, A. P.; Geyer, M. B.; Dorsey, C.; Zelenetz, A. D.; Mato, A. R.
Blood (2019)

Fulltext@MSK | Save

Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma

Meeting Abstract

Moskowitz, A. J.; Ghione, P.; Jacobsen, E. D.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Hancock, H.; Davey, T.; Obadi, O.; more...
Blood (2019)

Fulltext@MSK | Save

Evaluation of biomarkers as predictors of blinatumomab toxicity and real-world management of blinatumomab toxicity in B-acute lymphoblastic leukemia patients

Meeting Abstract

King, A. C.; Park, J. H.; Geyer, M. B.
Blood (2019)

Fulltext@MSK | Save

Real world chart review of blinatumomab to treat patients with high disease burden of relapsed or refractory B-cell precursor acute lymphoblastic leukemia